DxConference is the premier venue for thought leaders and executives in personalized medicine seeking to successfully launch and grow new diagnostics. Participants bring perspectives from leading diagnostic companies, pharmaceutical manufacturers, payers, and other stakeholders.
The Spring 2018 edition will explore the rise of companion diagnostics and how pharma and diagnostics companies can collaborate to increase opportunities in a growing market.
Attendees will build their networks with decision makers in interactive professional and social settings, and come away better equipped to address opportunities and challenges in the diagnostics marketplace.
Who Should Attend?
DxConference is ideal for executives from diagnostics and pharmaceutical manufacturers, as well as Medical Directors, Reimbursement Directors, Case Managers, Sales and Marketing Directors, and leaders from other healthcare organizations with a strategic investment in diagnostics.
Keynote Speakers Brian Carey, Partner, Foley Hoag LLP Hannah Murphy,Executive Director, The Coalition for 21st Century Medicine John Stone,Vice President, BGR Government Affairs Click here to view the full agenda.
Pricing Early Registration Rate: $1,595 (ends February 8, 2018) Standard Rate: $1,895